University of Leeds   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Leeds United Kingdom (1824)

Organization Overview

First Clinical Trial
1993
NCT00002582
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Bradford Royal Infirmary | Bradford Teaching Hospitals NHS Foundation Trust | Chapel Allerton Hospital, Leeds | Clinical Trials Research Unit, Leeds | Cookridge Hospital | Institute of Rheumatic & Musculoskeletal Medicine, Chapel Allerton Hospital | Julia Brown | Leeds Cancer Centre at St. James's University Hospital | Leeds General Infirmary | Leeds Hospital - Leeds - UK | Leeds Institute of Cancer and Pathology, Wellcome Trust Brenner Buidling, St James Univeristy Hospital, Leeds | Leeds Institute of Clinical Trials Research | Leeds Institute of Molecular Medicine, University of Leeds | Leeds Institute of Rheumatic and Musculoskeletal Medicine | Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds, UK | Leeds Partnerships NHS Foundation Trust | Leeds Teaching Hospitals NHS Trust | Leeds Teaching Hospitals NHS Trust, Leeds, UK | Leeds University | National Co-Coordinating Investigator - St James's University Hospital UK | Prof Jamie Cavenagh | St James' Institute of Oncology, Leeds, UK | St James's Institute of Oncology, St James's University Hospital, Leeds. | St James's University Hospital | St James University Hospital, Leeds, UK | The Leeds Teaching Hospitals NHS Trust | The University of Leeds | Univeristy of Leeds, CTRU | University ofLeeds | University of Leeds | University of Leeds, United Kingdom